Mitesco, Inc. announced that effective June 6, 2023, it has appointed Ms. Sheila Schweitzer, a member of the Board of Directors since 2021, to the position of Chairman, replacing Mr. Tom Brodmerkel, who has completed his term as Chair. Mr. Brodmerkel will remain as CFO and Board member. Ms. Schweitzer was also appointed to the newly created position of Chief Operating Officer (COO), primarily responsible for directing the company's recently emphasized acquisitions strategy with a focus on healthcare technology and services, as well as new potential clinic operations.

Mr. Larry Diamond, CEO of Mitesco, stated his thanks to Mr. Brodmerkel for his support and guidance while Chairman. Mr. Diamond added his congratulations and thanks to Ms. Schweitzer and looks forward to working together to help in the re-start of Mitesco. Ms. Schweitzer has over 30 years of experience in the healthcare industry as a company founder, executive, investor, and outside advisor.

Most recently, from 2012 through 2017 she served as Founder and CEO of PatientMatters, LLC, a healthcare patient management company improving revenue realization for hospitals, Patient Matters was acquired by First Source in 2020. From 2003 through 2009 she was CEO of CareMedic Systems, an industry leader in proactive financial management for hospitals and providers. PatientMatters was acquired by Optum Insight in 2009.

From 2009 through 2011 she was Senior Vice President of Strategy at OptumInsight, a part of United Healthcare Group providing data, analytics, research, consulting, technology, and managed services solutions to hospitals, physicians, health plans, governmental and life sciences companies. From 2001 through 2003, she was COO for MedUnite, a provider of electronic healthcare transaction processing services. As an investor, in 2009 Ms. Schweitzer co-founded Blue Ox Healthcare Partners, a private equity firm investing growth capital in commercial-stage healthcare companies.

Ms. Schweitzer currently is an Executive Advisor with HLM Venture Partners, a venture capital firm investing exclusively in tech-enabled healthcare services, healthcare information technology, and medical device and diagnostics companies.